Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,615 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02839863Recruiting
Breast cancer care follow-up at UMC Utrecht with surveys
This study follows people with breast cancer who receive radiation at UMC Utrecht. It uses routinely collected medical data and questionnaires to better understand outcomes over the long term.
AlmeloAges 18 years+ - NCT06241599RecruitingPhase 2/Phase 3
AK104 with chemo for advanced nasopharyngeal cancer
This study tests if adding a new immunotherapy drug (called AK104) to standard chemotherapy can help people whose nasopharyngeal cancer has come back or spread after previous treatment. The goal is to see if the combination works better than chemotherapy alone.
Guangzhou, GuangdongAges 18–75 - NCT05760378RecruitingPhase 3
Famitinib plus immunotherapy for advanced triple-negative breast cancer
This Phase 3 trial tests a combination of famitinib (a cancer drug that targets blood vessel growth) with immunotherapy drugs in people with newly diagnosed advanced triple-negative breast cancer that has spread or cannot be fully removed. It aims to improve how long patients live and how well the cancer responds.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06183632Recruiting
Lipid study in healthy blood donors
This research study looks at tiny particles in the blood called microparticles and their fat content. It aims to understand these particles in healthy people, which helps in future research on diseases.
DijonAges 18 years+ - NCT02049658Recruiting
Using a sniff dog to check for suspected tumors
This trial studies whether a trained sniff dog can help detect or rule out tumors in people with suspicious spots and in healthy people without tumors. It may be useful as a quick screening tool alongside regular medical tests.
Changsha, HunanAges 1 year+ - NCT04282044RecruitingPhase 1
CRX100 drug trial for advanced cancers with or without pembrolizumab
This Phase 1 trial tests CRX100 (a new cancer medicine) alone and with pembrolizumab (an immune checkpoint drug) in people with advanced solid tumors. It’s mainly designed to check safety and side effects, and to see whether tumors respond, potentially helping people whose cancer has come back or stopped responding to standard treatment.
Scottsdale, ArizonaAges 18 years+ - NCT05199376Recruiting
Cryotherapy treatment for painful, hard-to-remove NF1 tumors
This trial tests whether freezing treatment done through the skin (cryotherapy) can reduce pain and discomfort from certain non-cancer NF1 tumors that can’t be safely removed. You may be able to join if you’re an adult with NF1, a painful or bothersome benign lesion, and can safely undergo procedures like MRI.
LyonAges 18 years+ - NCT06202404Recruiting
Predicting cancer spread with a new imaging tool
This trial tests if a special imaging analysis can predict where your cancer might spread. It's for people with advanced lung, colorectal, or breast cancer who are starting or continuing treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06259162Recruiting
LAG3 study in triple-negative breast cancer
This trial is studying a protein called LAG3 in triple-negative breast cancer. It is for people who will receive chemotherapy before surgery to see if LAG3 levels affect how well the treatment works.
SeoulAges Any age - NCT07863193RecruitingPhase 3
Denifanstat for moderate to severe acne
This trial tests an experimental pill called denifanstat to see if it can clear up moderate to severe acne. If you qualify, you may receive the study drug or a placebo, and researchers will check how well it works on your skin over time.
Bryant, ArkansasAges 12 years+ - NCT07868640Recruiting
Blood test validation for multiple cancer types
This study collects blood samples from people being treated for certain cancers to check if a new blood test (TST79) can help detect or monitor cancer. If you have one of the listed cancer types and are currently receiving treatment, you may be able to take part.
Charleroi, HainautAges 18 years+ - NCT05999149RecruitingPhase 3
Famitinib plus chemo and immunotherapy before breast cancer surgery
This trial tests whether adding a targeted therapy pill (famitinib) to standard chemo plus an immunotherapy (camrelizumab) can shrink triple negative breast cancer before surgery. It may help people with earlier-stage disease who have not had certain prior treatments.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT05747261RecruitingPhase 1/Phase 2
Single-dose gene therapy for children with spinal muscular atrophy
This trial tests a one-time gene therapy given through a vein to add a working SMN gene in children with spinal muscular atrophy (SMA). It mainly looks at safety first, and also checks early signs that treatment helps the disease.
MinskAges Up to 8 months - NCT06272552Recruiting
Understanding patient feedback in kidney, cancer, and surgery care
This study aims to understand how patients' feedback and health information can be collected during routine care to improve treatment and communication. It focuses on people being treated for kidney disease, prostate cancer, breast cancer, or bariatric surgery, and will use online tools to gather your input.
Barcelona, CataloniaAges 18 years+ - NCT07855627Recruiting
Predicting lymphedema risk before surgery
This study looks at whether a simple measurement taken before surgery can help predict if you might develop lymphedema (arm swelling) after treatment. It is for women with newly diagnosed inflammatory breast cancer who are planning to have standard treatments.
Houston, TexasAges 18 years+ - NCT05062837RecruitingPhase 2/Phase 3
Surgery plus two drugs for advanced liver cancer
This trial combines surgery to remove liver tumors with two drugs, camrelizumab (an immunotherapy that helps your immune system fight cancer) and apatinib (a targeted therapy that may cut off the tumor's blood supply). It aims to see if this combination helps people with advanced liver cancer that has spread outside the liver (but not to the brain) and who have chosen not to have other standard treatments like TACE or radiation. Participating could potentially control the spreading cancer and improve outcomes.
NanningAges 18–75 - NCT06281145Recruiting
Stress reduction for breast or colon cancer patients
This study tests a stress-reducing program for people with breast or colon cancer. It uses a technique called heart rate variability biofeedback to help you manage stress during treatment.
BratislavaAges 18 years+ - NCT06281210Recruiting
Test to skip breast surgery after chemo
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
Candiolo, TurinAges 18 years+ - NCT06282796Recruiting
Early heart risk monitoring for breast cancer chemo
This study tests a method to predict and warn about heart damage from a common type of breast cancer chemotherapy. If you have HER2-positive breast cancer and will receive anthracycline drugs, this trial may help monitor your heart health.
Fuzhou, FujianAges 18–80 - NCT06286267Recruiting
AI tool for diagnosing breast phyllodes tumors
This trial uses an artificial intelligence system to help doctors more accurately diagnose and predict the outcome of breast phyllodes tumors, which are rare breast growths. It aims to improve how these tumors are identified and managed.
Guangzhou, GuangdongAges Any age - NCT06291597Recruiting
Vaping study: effects on lungs and heart
This study is looking at how daily vaping affects your lungs and heart over time. If you vape every day, researchers want to monitor your health to spot any early warning signs.
QuébecAges 18 years+ - NCT06101082RecruitingPhase 1
Testing anti-HER2-CAR-T cells for advanced solid tumors
This study tests a new type of cell therapy called anti-HER2-CAR-T for people with advanced HER2-positive solid tumors (like breast, stomach, or colon cancer) whose cancer has not responded to other treatments. The therapy uses your own immune cells engineered to target and kill cancer cells.
Shenyang, LiaoningAges 18–70 - NCT05789901Recruiting
Using a Facebook chatbot to share health information
This study tests whether a Facebook Messenger chatbot can provide helpful health information for different conditions. You may help researchers check if people can use the chatbot and understand the information.
Montreal, QuebecAges 14 years+ - NCT06091774Recruiting
Digital therapy for heart disease risk factors
This study tests a smartphone app (iATROS) for managing heart disease risk factors in patients with coronary heart disease. If you have had a heart attack, a stent, angioplasty, or bypass surgery, and you can use a smartphone, this program may help you reduce your risk through digital monitoring and guidance.
Munich, BavariaAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,615 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.